摘要
背景:Ca2 +流入在几种神经系统疾病的生理和病理生理过程中起重要作用。瞬时受体电位通道(TRPCs)形成一系列电压敏感的钙离子通道。 目的:在本次综述中,我们将讨论临床受体潜能规范(TRPC)通道的重要性,这是一个至关重要的钙通道家族。本文回顾了TRPC通道在脑出血,脑梗死后出血性转化,蛛网膜下腔出血和脑损伤等疾病发病机制中的作用。 结果:TRPC在中枢神经系统(CNS)中表达特别高,涉及几种生理功能。 TRPC家族与蛛网膜下腔出血后脑血管痉挛,脑内出血后神经元损伤,脑缺血后NMDA细胞毒性,神经系统肿瘤,神经退行性疾病,神经痴呆等疾病有关。 结论:TRPC家族功能丰富,分布广泛,各种神经系统疾病功能不同。
关键词: 脑损伤,Ca2 +,出血性转化,脑内出血,神经系统,蛛网膜下腔出血,TRPCs。
图形摘要
Current Drug Targets
Title:Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System
Volume: 18 Issue: 12
关键词: 脑损伤,Ca2 +,出血性转化,脑内出血,神经系统,蛛网膜下腔出血,TRPCs。
摘要: Background: Ca2+ influx plays an essential role in the physiological and pathophysiologic processes of several nervous system diseases. The transient receptor-potential channels (TRPCs) form a family of voltage –sensitive calcium ion channels.
Objective: In this review, we will discuss the importance of transient receptor potential canonical (TRPC) channels, which is a crucial family of calcium channels. This article reviews the role of TRPC channels in the pathogenesis of diseases such as brain hemorrhage, hemorrhagic transformation after cerebral infarction, subarachnoid hemorrhage, and brain injury. Results: TRPC has especially high expression in the central nervous system (CNS), and was involved in several physiological functions. The TRPC family is associated with cerebral vasospasm after subarachnoid hemorrhage, neuronal damage after intracerebral hemorrhage, NMDA cytotoxicity in cerebral ischemia, nervous system tumors, neurodegenerative diseases, neural addiction and other diseases. Conclusion: The TRPC family has rich functionality and is widely distributed, with different functions in various nervous system diseases.Export Options
About this article
Cite this article as:
Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System, Current Drug Targets 2017; 18 (12) . https://dx.doi.org/10.2174/1389450117666151209120007
DOI https://dx.doi.org/10.2174/1389450117666151209120007 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) New Therapeutic Approaches to Arterial Calcification Via Inhibition of Transglutaminase andβ-Catenin Signalin
Current Pharmaceutical Design Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets
Current Drug Targets An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)
Current Drug Targets - Cardiovascular & Hematological Disorders Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
Current Pharmaceutical Biotechnology New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
Recent Patents on Anti-Cancer Drug Discovery Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Current Pharmaceutical Design Fractional Flow Reserve: Physiological Basis, Advantages and Limitations, and Potential Gender Differences
Current Cardiology Reviews Pompe Disease: From New Views on Pathophysiology to Innovative Therapeutic Strategies
Current Pharmaceutical Biotechnology Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure
Current Pharmaceutical Design Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry The Critical Role of Insulin-Like Growth Factor-1 Isoforms in the Physiopathology of Skeletal Muscle
Current Genomics Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Amiodarone - A ‘Broad Spectrum’ Antiarrhythmic Drug
Cardiovascular & Hematological Disorders-Drug Targets The Effect of Licorice Drink on the Systemic Exposure of Verapamil in Rabbits
Drug Metabolism Letters